Saudi approves Pfizer's COVID-19 vaccine for age group 5-11

Pfizer

CAIRO, Nov 3 (Reuters) - The Saudi Food and Drug Authority said on Wednesday it had given its approval to use Pfizer's (PFE.N) COVID-19 vaccine for those between five and eleven years of age.

The authority added in a statement its decision was "based on data provided by the company, which showed the vaccine met the special regulatory requirements".